Spectral AI, Inc. (MDAI)
NASDAQ: MDAI · Real-Time Price · USD
1.130
-0.150 (-11.72%)
At close: Mar 28, 2025, 4:00 PM
1.120
-0.010 (-0.88%)
After-hours: Mar 28, 2025, 7:41 PM EDT

Company Description

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States.

The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.

Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals.

The company is headquartered in Dallas, Texas.

Spectral AI, Inc.
Spectral AI logo
Country United States
Founded 2013
Industry Medical Devices
Sector Healthcare
Employees 78
CEO Peter Carlson

Contact Details

Address:
2515 McKinney Avenue, Suite 1000
Dallas, Texas 75201
United States
Phone 972 499 4934
Website spectral-ai.com

Stock Details

Ticker Symbol MDAI
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001833498
CUSIP Number 84757T105
ISIN Number US84757T1051
SIC Code 3841

Key Executives

Name Position
Erich L. Spangenberg Chief Executive Officer of Health care and Director
Wensheng Fan Co-Founder, Chief Innovation Strategist and Senior Advisor to the Chief Executive Officer
Vincent Stanley Capone Chief Financial Officer, General Counsel and Corporate Secretary
Christine Marks Vice President of Marketing and Commercialization
Dr. John Michael DiMaio M.D. Founder and Chairman
Stan Micek Interim Chief Operating Officer
Prof. Paul Chadwick Executive Vice President of UK and EMEA
Jeremiah A. Sparks MBA Chief Commercialization Officer
David Bronson Financial Controller

Latest SEC Filings

Date Type Title
Mar 26, 2025 8-K Current Report
Mar 21, 2025 424B5 Filing
Mar 17, 2025 8-K Current Report
Mar 4, 2025 8-K Current Report
Mar 4, 2025 8-K Current Report
Mar 4, 2025 8-K Current Report
Dec 23, 2024 8-K Current Report
Dec 12, 2024 424B5 Filing
Dec 11, 2024 8-K Current Report
Dec 9, 2024 424B5 Filing